TGF-β acts as a potent chemoattractant for neutrophils [166], and inhibition of TGF-β signaling has been shown to enforce the anti-tumoral phenotype in tumor-associated neutrophils (TANs) that includes cytolytic activity and increased expression of pro-inflammatory cytokines [167]. Here, TGFB1 is linked to neoplasm.